Evaluation of therapeutic interventions for vaccinia virus keratitis

Journal of Infectious Diseases

Volumn 203, Issue 5, 2011, Pages 683-690

  Altmann, Sharon ^a   Brandt, Curtis R ^a   Murphy, Christopher J ^a,c,d   Patnaikuni, Ravi ^b   Takla, Teresa ^b   Toomey, Megan ^a   Nesbit, Brittany ^a   McIntyre, Kimberly ^a   Covert, Jill ^a,d   Dubielzig, Richard ^a   Leatherberry, Gary ^a   Adkins, Elizabeth ^a   Kodihalli, Shantha ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Cangene Corporation   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN; PREDNISOLONE ACETATE; TRIFLURIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MACDONALD SHADDUCK SCORING SYSTE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPEATED DRUG DOSE; SCORING SYSTEM; SINGLE DRUG DOSE; VACCINIA VIRUS; VACCINIA VIRUS KERATITIS; VIRAL CLEARANCE; VIRUS KERATITIS; VIRUS STRAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BLINDNESS; CERCOPITHECUS AETHIOPS; CORNEA; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELA CELLS; HUMANS; IMMUNOGLOBULINS; INFUSIONS, INTRAVENOUS; KERATITIS; PREDNISOLONE; RABBITS; RANDOM ALLOCATION; SMALLPOX VACCINE; TRIFLURIDINE; VACCINIA VIRUS; VERO CELLS;

EID: 79751481752     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq103     Document Type: Article

References (25)

1. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med 1969; 281:1201-8.
2. Ruben FL, Lane JM. Ocular vaccinia: an epidemiologic analysis of 348 cases. Arch Ophthalmol 1970; 84:45-8.
3. Duke-Elder S. Diseases of the outer eye. In Duke-Elder S, ed. System of ophthalmology. Vol. 8. St Louis: CV Mosby, 1965.
4. Pepose JS, Margolis TP, LaRussa P, Pavan-Langston D. Ocular complications of smallpox vaccination. Am J Ophthalmol 2003; 136:343-52. (Pubitemid 36904085)
5. Rotz LD, Dotson DA, Damon IK, Becher JA. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001; 50:1-25.
6. Fulginiti VA, Winograd LA, Jackson M, Ellis P. Therapy of experimental vaccinal keratitis: effect of idoxuridine and VIG. Arch Ophthalmol 1965; 74:539-44.
7. Jones BR, Al-Hussaini MK. Therapeutic considerations in ocular vaccinia. Trans Ophthalmol Soc UK 1963; 83:613-31.
8. Rennie AG, Cant JS, Foulds WS, Pennington TH, Timbury MC. Ocular vaccinia. Lancet 1974; 2:273-5.
9. Rydberg M, Pandolfi M. Treatment of vaccinia keratitis with postvaccinial gamma globulin. Acta Ophthalmol (Copenh) 1963; 41:713-8.
10. Jones BR, Galbraith JE, Al-Hussaini MK. Vaccinial keratitis treated with interferon. Lancet 1962; 1:875-9.
11. Jack MK, Sorenson RW. Vaccinial keratitis treated with IDU. Arch Ophthalmol 1963; 69:730-2.
12. Kaufman HL, Nesburn AB, Maloney ED. Cure of vaccinia infection by 5-iodo-2′-deoxyuridine. Virology 1962; 18:567-9.
13. Kimura SJ, Thygeson P, Geller HO. Observations on the effect of adrenal steroids on vaccinia virus. I. The effect of cortisone in experimental vaccinia-virus keratoconjunctivitis of the rabbit. Am J Ophthalmol 1953; 36:116-20.
14. Sudarsky RD. Postvaccinial disciform keratitis; recurrent episodes treated with steroids. Am J Ophthalmol 1957; 44:810-2.
15. Hyndiuk RA, Seideman S, Leibsohn JM. Treatment of vaccinial keratitis with trifluorothymidine. Arch Ophthalmol 1976; 94:1785-6. (Pubitemid 8263679)
16. Parkhurst JR. Danenberg PV, Heidelberger C. Growth inhibition of cells in cultures and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine. Chemotherapy 1976; 22:221-31.
17. Fillmore GL, Ward TP, Bower KS, et al. Ocular complications in the Department of Defense Smallpox Vaccination Program. Ophthalmology 2004; 111:2086-93. (Pubitemid 39446729)
18. Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR. Inhibition of vaccinia virus entry by a broad spectrum antiviral peptide. Virology 2009; 388:248-59.
19. Altmann S, Emanuel A, Toomey M, et al. A quantitative rabbit model of vaccinia keratitis. Invest Ophthalmol Vis Sci 2010; 51:4531-40.
20. CDC. Adverse reaction to smallpox vaccine. Commun Dis Rep CDR Wkly 1994; 4:157.
21. Baggs J, Chen RT, Damon IK, et al. Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program. Clin Infect Dis 2005; 40:1133-40. (Pubitemid 40490238)
22. Casey CG, Iskander JK, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005; 294:2734-43.
23. Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Smallpox vaccination: a review, part II. Adverse events. Clin Infect Dis 2003; 37:251-71.
24. Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep 2003; 52:1-28.
25. Heidelberger C. On the molecular mechanism of the antiviral activity of trifluorothymidine. Ann N Y Acad Sci 1975; 255:317-25.